A Correlative Study of Clinical Features, Ultrasound Findings, and Biochemical Markers in PCOS
Authors/Creators
- 1. Assistant professor, Department of Radiodiagnosis, GMERS Medical College, Morbi, Gujarat
- 2. Consultant Radiologist, Accuracy Diagnostic Centre, Morbi, Gujarat, India
- 3. Consultant Radiologist, Wankaner, Gujarat
Description
Introduction: Polycystic Ovarian Syndrome (PCOS) is a common endocrine disorder in women of reproductive age, marked by hormonal imbalances, metabolic disruptions, and reproductive abnormalities. Clinical features such as irregular cycles, hirsutism, and obesity, combined with ultrasonographic findings like multiple small follicles and elevated biochemical markers, necessitate a comprehensive diagnostic approach to understand and manage PCOS effectively. Material and Methods: This prospective study was conducted over a year at a tertiary care center in Western Gujarat, including 60 PCOS patients and 20 healthy controls. Participants underwent detailed clinical evaluations, ultrasonographic imaging, and biochemical analysis, adhering to the Rotterdam criteria for PCOS diagnosis. Key parameters like BMI, hormone levels, and ovarian morphology were assessed to investigate the clinical, ultrasonographic, and biochemical correlates of PCOS. Data analysis included descriptive statistics and correlation tests, with a p-value of <0.05 considered statistically significant. Results: Our study demonstrated significant clinical, hormonal, and immunological differences between PCOS patients and healthy controls. The study group showed a high prevalence of hirsutism (70%), oligomenorrhea (66.67%), and polycystic ovaries on ultrasonography (63.33%), all absent in the control group (p < 0.001). BMI (28.95 ± 6.15 kg/m²), LH levels (12.75 ± 4.25 mIU/mL), and the LH-FSH ratio (2.15 ± 0.95) were significantly elevated in the study group (p < 0.001), alongside increased anti-TPO antibody levels in patients with polycystic ovaries (65.50 ± 85.25 IU/mL, p < 0.001). While fasting blood sugar, prolactin, and TSH levels showed no significant differences, strong correlations between BMI, LH, and anti-TPO levels highlight the intricate interplay of metabolic, hormonal, and immunological factors in PCOS. Conclusion: Our study identifies significant correlations between clinical features, ultrasound findings, and biochemical markers in PCOS patients, emphasizing the role of thyroid autoimmunity, BMI, and hormonal imbalances. These results highlight the value of integrated diagnostic approaches for effective management of PCOS.
Abstract (English)
Introduction: Polycystic Ovarian Syndrome (PCOS) is a common endocrine disorder in women of reproductive age, marked by hormonal imbalances, metabolic disruptions, and reproductive abnormalities. Clinical features such as irregular cycles, hirsutism, and obesity, combined with ultrasonographic findings like multiple small follicles and elevated biochemical markers, necessitate a comprehensive diagnostic approach to understand and manage PCOS effectively. Material and Methods: This prospective study was conducted over a year at a tertiary care center in Western Gujarat, including 60 PCOS patients and 20 healthy controls. Participants underwent detailed clinical evaluations, ultrasonographic imaging, and biochemical analysis, adhering to the Rotterdam criteria for PCOS diagnosis. Key parameters like BMI, hormone levels, and ovarian morphology were assessed to investigate the clinical, ultrasonographic, and biochemical correlates of PCOS. Data analysis included descriptive statistics and correlation tests, with a p-value of <0.05 considered statistically significant. Results: Our study demonstrated significant clinical, hormonal, and immunological differences between PCOS patients and healthy controls. The study group showed a high prevalence of hirsutism (70%), oligomenorrhea (66.67%), and polycystic ovaries on ultrasonography (63.33%), all absent in the control group (p < 0.001). BMI (28.95 ± 6.15 kg/m²), LH levels (12.75 ± 4.25 mIU/mL), and the LH-FSH ratio (2.15 ± 0.95) were significantly elevated in the study group (p < 0.001), alongside increased anti-TPO antibody levels in patients with polycystic ovaries (65.50 ± 85.25 IU/mL, p < 0.001). While fasting blood sugar, prolactin, and TSH levels showed no significant differences, strong correlations between BMI, LH, and anti-TPO levels highlight the intricate interplay of metabolic, hormonal, and immunological factors in PCOS. Conclusion: Our study identifies significant correlations between clinical features, ultrasound findings, and biochemical markers in PCOS patients, emphasizing the role of thyroid autoimmunity, BMI, and hormonal imbalances. These results highlight the value of integrated diagnostic approaches for effective management of PCOS.
Files
IJTPR,Vol14,Issue11,Article25.pdf
Additional details
Dates
- Accepted
-
2024-10-26
Software
References
- 1. Li Y, Chen C, Ma Y, Xiao J, Luo G, Li Y, et al. Multi-system reproductive metabolic disorder: significance for the pathogenesis and therapy of polycystic ovary syndrome (PCOS). Life Sci. 2019; 228:167–75. 2. Stener-Victorin E, Teede H, Norman RJ, Legro R, Goodarzi MO, Dokras A, et al. Polycystic ovary syndrome. Nat Rev Dis Primer. 2024; 10(1):27. 3. Bjekić-Macut J, Vukašin T, Velija-Ašimi Z, Bureković A, Zdravković M, Andrić Z, et al. Polycystic ovary syndrome: a contemporary clinical approach. Curr Pharm Des. 2021; 27(36):3812–20. 4. Thaker N, Dhande R, Parihar P. Role of Transvaginal Sonography in the Diagnosis of Female Infertility: A Comprehensive Review. Cureus. 2023; 15(12). 5. Tay CT, Hart RJ, Hickey M, Moran LJ, Earnest A, Doherty DA, et al. Updated adolescent diagnostic criteria for polycystic ovary syndrome: impact on prevalence and longitudinal body mass index trajectories from birth to adulthood. BMC Med. 2020; 18:1–11. 6. Dutt S, Chadha S, Gupta V. Comparison of Clinical, Biochemical, and Sonological Parameters in Adolescents with and without Polycystic Ovarian Syndrome. Ann Natl Acad Med Sci India. 2022; 58(04):197–203. 7. Sanchez-Garrido MA, Tena-Sempere M. Metabolic dysfunction in polycystic ovary syndrome: Pathogenic role of androgen excess and potential therapeutic strategies. Mol Metab. 2020; 35:100937. 8. Patel S. Polycystic ovary syndrome (PCOS), an inflammatory, systemic, lifestyle endocrinopathy. J Steroid Biochem Mol Biol. 2018; 182:27–36. 9. Kumar N, Agarwal H. Early clinical, biochemical and radiological features in obese and non-obese young women with polycystic ovarian syndrome: a comparative study. Horm Metab Res. 2022; 54(09):620–4. 10. Inan C, Karadag C. Correlation between ovarian morphology and biochemical and hormonal parameters in polycystic ovary syndrome. Pak J Med Sci. 2016; 32(3):742. 11. Guo Z, Jin F, Chen S, Hu P, Hao Y, Yu Q. Correlation between biochemical and clinical hyperandrogenism parameter in polycystic ovary syndrome in relation to age. BMC Endocr Disord. 2023; 23(1):89. 12. Mahran A. The relationship between Antimüllerian hormone and the clinical, biochemical and sonographic parameters in women with polycystic ovarian syndrome. Middle East Fertil Soc J. 2016; 21(1):11–5. 13. Gupta V, Sharma S, Raina SK, Bedi GK. Clinical, ultrasonographic, and biochemical correlates of polycystic ovarian syndrome: A case–control study from a Tertiary Care Center in North India. J Sci Soc. 2018; 45(1):8–12. 14. Fulghesu AM, Angioni S, Frau E, Belosi C, Apa R, Mioni R, et al. Ultrasound in polycystic ovary syndrome—the measuring of ovarian stroma and relationship with circulating androgens: results of a multicentric study. Hum Reprod. 2007; 22(9):2501–8. 15. Rita D, Geethanjali M, Reddy KS. A correlation of clinical, hormonal and ultrasonography features of polycystic ovarian syndrome among adolescent and reproductive age group women attending OPD in Navodaya medical college. Int J Reprod Contracept Obstet Gynecol. 2023; 12(7):2123–8. 16. Ahmed AA, Moselhy SS, Kumosani TA, Huwait EA, Al-Ghamdi MA, Al-Madani KA, et al. Ultrasonographic and biochemical assessments as early prediction of polycystic ovarian syndrome in obese women. Afr Health Sci. 2020; 20(2):676–81. 17. Rackow BW, Brink HV, Hammers L, Flannery CA, Lujan ME, Burgert TS. Ovarian morphology by transabdominal ultrasound correlates with reproductive and metabolic disturbance in adolescents with PCOS. J Adolesc Health. 2018; 62(3):288–93. 18. Moschos E, Twickler DM. Prediction of polycystic ovarian syndrome based on ultrasound findings and clinical parameters. J Clin Ultrasound. 2015; 43(3):157–63. 19. Ashwini Sidhmalswamy G, Ghongdemath JS, Venkatesh S. Clinical, ultrasonographical and hormonal correlation in women with polycystic ovarian syndrome. Int J Reprod Contracept Obstet Gynecol. 2018; 7(12):5134– 9.